Neuropsychiatric Outcome of Children Born to Women With Systemic Lupus Erythematosus and Exposed in Utero to Azathioprine: A Case-Control Study
Objective: The long-term outcome of children born to SLE mothers still represents a controversial topic in literature, with some studies reporting a possible increased prevalence of different neurologic and psychiatric diseases (NPD), including neurodevelopmental disorders (ND), and in particular le...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-12-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2020.613239/full |
id |
doaj-20573fbd6b6a4f228de8b2f9ce77b19a |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Maria-Grazia Lazzaroni Maria-Grazia Lazzaroni Laura Andreoli Laura Andreoli Francesca Crisafulli Francesca Crisafulli Francesco Tamborini Irene Debeni Valentina Binda Cecilia Nalli Jessica Galli Jessica Galli Elisa Fazzi Elisa Fazzi Gabriella Moroni Franco Franceschini Franco Franceschini Angela Tincani Angela Tincani Angela Tincani |
spellingShingle |
Maria-Grazia Lazzaroni Maria-Grazia Lazzaroni Laura Andreoli Laura Andreoli Francesca Crisafulli Francesca Crisafulli Francesco Tamborini Irene Debeni Valentina Binda Cecilia Nalli Jessica Galli Jessica Galli Elisa Fazzi Elisa Fazzi Gabriella Moroni Franco Franceschini Franco Franceschini Angela Tincani Angela Tincani Angela Tincani Neuropsychiatric Outcome of Children Born to Women With Systemic Lupus Erythematosus and Exposed in Utero to Azathioprine: A Case-Control Study Frontiers in Pharmacology azathioprine offspring neurodevelopmental disorders learning disabilities pregnancy systemic lupus erythematosus |
author_facet |
Maria-Grazia Lazzaroni Maria-Grazia Lazzaroni Laura Andreoli Laura Andreoli Francesca Crisafulli Francesca Crisafulli Francesco Tamborini Irene Debeni Valentina Binda Cecilia Nalli Jessica Galli Jessica Galli Elisa Fazzi Elisa Fazzi Gabriella Moroni Franco Franceschini Franco Franceschini Angela Tincani Angela Tincani Angela Tincani |
author_sort |
Maria-Grazia Lazzaroni |
title |
Neuropsychiatric Outcome of Children Born to Women With Systemic Lupus Erythematosus and Exposed in Utero to Azathioprine: A Case-Control Study |
title_short |
Neuropsychiatric Outcome of Children Born to Women With Systemic Lupus Erythematosus and Exposed in Utero to Azathioprine: A Case-Control Study |
title_full |
Neuropsychiatric Outcome of Children Born to Women With Systemic Lupus Erythematosus and Exposed in Utero to Azathioprine: A Case-Control Study |
title_fullStr |
Neuropsychiatric Outcome of Children Born to Women With Systemic Lupus Erythematosus and Exposed in Utero to Azathioprine: A Case-Control Study |
title_full_unstemmed |
Neuropsychiatric Outcome of Children Born to Women With Systemic Lupus Erythematosus and Exposed in Utero to Azathioprine: A Case-Control Study |
title_sort |
neuropsychiatric outcome of children born to women with systemic lupus erythematosus and exposed in utero to azathioprine: a case-control study |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Pharmacology |
issn |
1663-9812 |
publishDate |
2020-12-01 |
description |
Objective: The long-term outcome of children born to SLE mothers still represents a controversial topic in literature, with some studies reporting a possible increased prevalence of different neurologic and psychiatric diseases (NPD), including neurodevelopmental disorders (ND), and in particular learning disorders (LD). Different risk factors have been advocated, such as the in utero exposure to auto-antibodies and drugs, particularly Azathioprine (AZA).Methods: A case-control study was designed to compare pregnancies treated with AZA (cases) with those not treated with AZA (controls). All the pregnancies had been prospectively followed in two Italian centers. The match was based upon renal involvement, antiphospholipid (aPL) status, maternal age at pregnancy (±5 years) and child’s age at the time of the study (±2 years). SLE mothers were interviewed by a telephone survey, particularly focused on the presence of a certified NPD in their children ≥6 years of age.Results: Twenty-seven cases and 65 controls were similar in terms of demographic, immunological and clinical features, except for a higher rate of SLE flares during pregnancy in cases (22.2% vs. 10.8%, p:0.191). The 92 children had a mean age of 14.0 years at the time of the survey; 11 had at least one NPD (12.0%). The frequency of each single NPD was similar to that of the general pediatric population and no association was found with either the in utero exposure to AZA, or other specific factors (auto-antibodies, disease activity, obstetric complications, prematurity).Conclusion: The long-term neuropsychiatric outcome of the children born to SLE mothers did not show neither an increased frequency of NPD as compared to the general pediatric population nor a specific pattern of NPD. The in utero exposure to AZA was not associated with the development of NPD in this case-control study of prospectively-followed pregnancies. NPD are complex conditions and large prospective studies are needed to capture the wide range of variables that may contribute to their development in the offspring of SLE women. |
topic |
azathioprine offspring neurodevelopmental disorders learning disabilities pregnancy systemic lupus erythematosus |
url |
https://www.frontiersin.org/articles/10.3389/fphar.2020.613239/full |
work_keys_str_mv |
AT mariagrazialazzaroni neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy AT mariagrazialazzaroni neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy AT lauraandreoli neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy AT lauraandreoli neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy AT francescacrisafulli neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy AT francescacrisafulli neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy AT francescotamborini neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy AT irenedebeni neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy AT valentinabinda neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy AT cecilianalli neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy AT jessicagalli neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy AT jessicagalli neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy AT elisafazzi neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy AT elisafazzi neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy AT gabriellamoroni neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy AT francofranceschini neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy AT francofranceschini neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy AT angelatincani neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy AT angelatincani neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy AT angelatincani neuropsychiatricoutcomeofchildrenborntowomenwithsystemiclupuserythematosusandexposedinuterotoazathioprineacasecontrolstudy |
_version_ |
1724381712782196736 |
spelling |
doaj-20573fbd6b6a4f228de8b2f9ce77b19a2020-12-16T05:27:16ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122020-12-011110.3389/fphar.2020.613239613239Neuropsychiatric Outcome of Children Born to Women With Systemic Lupus Erythematosus and Exposed in Utero to Azathioprine: A Case-Control StudyMaria-Grazia Lazzaroni0Maria-Grazia Lazzaroni1Laura Andreoli2Laura Andreoli3Francesca Crisafulli4Francesca Crisafulli5Francesco Tamborini6Irene Debeni7Valentina Binda8Cecilia Nalli9Jessica Galli10Jessica Galli11Elisa Fazzi12Elisa Fazzi13Gabriella Moroni14Franco Franceschini15Franco Franceschini16Angela Tincani17Angela Tincani18Angela Tincani19Department of Clinical and Experimental Sciences, University of Brescia, Brescia, ItalyRheumatology and Clinical Immunology Unit, ASST Spedali Civili of Brescia, Brescia, ItalyDepartment of Clinical and Experimental Sciences, University of Brescia, Brescia, ItalyRheumatology and Clinical Immunology Unit, ASST Spedali Civili of Brescia, Brescia, ItalyDepartment of Clinical and Experimental Sciences, University of Brescia, Brescia, ItalyRheumatology and Clinical Immunology Unit, ASST Spedali Civili of Brescia, Brescia, ItalyNephrology Unit, IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, ItalyDepartment of Clinical and Experimental Sciences, University of Brescia, Brescia, ItalyNephrology Unit, IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, ItalyRheumatology and Clinical Immunology Unit, ASST Spedali Civili of Brescia, Brescia, ItalyDepartment of Clinical and Experimental Sciences, University of Brescia, Brescia, ItalyNeuropsychiatry Unit, Children’s Hospital, ASST Spedali Civili of Brescia, Brescia, ItalyDepartment of Clinical and Experimental Sciences, University of Brescia, Brescia, ItalyNeuropsychiatry Unit, Children’s Hospital, ASST Spedali Civili of Brescia, Brescia, ItalyNephrology Unit, IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, ItalyDepartment of Clinical and Experimental Sciences, University of Brescia, Brescia, ItalyRheumatology and Clinical Immunology Unit, ASST Spedali Civili of Brescia, Brescia, ItalyDepartment of Clinical and Experimental Sciences, University of Brescia, Brescia, ItalyRheumatology and Clinical Immunology Unit, ASST Spedali Civili of Brescia, Brescia, ItalyI.M. Sechenov First Moscow State Medical University, Moscow, RussiaObjective: The long-term outcome of children born to SLE mothers still represents a controversial topic in literature, with some studies reporting a possible increased prevalence of different neurologic and psychiatric diseases (NPD), including neurodevelopmental disorders (ND), and in particular learning disorders (LD). Different risk factors have been advocated, such as the in utero exposure to auto-antibodies and drugs, particularly Azathioprine (AZA).Methods: A case-control study was designed to compare pregnancies treated with AZA (cases) with those not treated with AZA (controls). All the pregnancies had been prospectively followed in two Italian centers. The match was based upon renal involvement, antiphospholipid (aPL) status, maternal age at pregnancy (±5 years) and child’s age at the time of the study (±2 years). SLE mothers were interviewed by a telephone survey, particularly focused on the presence of a certified NPD in their children ≥6 years of age.Results: Twenty-seven cases and 65 controls were similar in terms of demographic, immunological and clinical features, except for a higher rate of SLE flares during pregnancy in cases (22.2% vs. 10.8%, p:0.191). The 92 children had a mean age of 14.0 years at the time of the survey; 11 had at least one NPD (12.0%). The frequency of each single NPD was similar to that of the general pediatric population and no association was found with either the in utero exposure to AZA, or other specific factors (auto-antibodies, disease activity, obstetric complications, prematurity).Conclusion: The long-term neuropsychiatric outcome of the children born to SLE mothers did not show neither an increased frequency of NPD as compared to the general pediatric population nor a specific pattern of NPD. The in utero exposure to AZA was not associated with the development of NPD in this case-control study of prospectively-followed pregnancies. NPD are complex conditions and large prospective studies are needed to capture the wide range of variables that may contribute to their development in the offspring of SLE women.https://www.frontiersin.org/articles/10.3389/fphar.2020.613239/fullazathioprineoffspringneurodevelopmental disorderslearning disabilitiespregnancysystemic lupus erythematosus |